Foley & Lardner LLP announced today that the firm has bolstered its Innovative Technology and Health Care & Life Sciences Sectors with the addition of Brian Tomkins as a partner in the Mechanical & Electromechanical Technologies Practice Group. Tomkins, who joins Foley’s New York office, is the latest testament to the firm’s strategic expansion on the East Coast and its offerings across key practices and sectors.
Tomkins’ practice encompasses all areas of intellectual property, including global IP strategy, due diligence, clearance, litigation, and transactional work such as mergers and acquisitions, licensing, development agreements, and joint ventures. He advises clients across a wide range of industries, with a particular focus on medical devices, biotechnology, pharmaceuticals, software, blockchain, and financial services. Tomkins also provides strategic counseling on the acquisition, protection, and commercialization of new technologies and product lines.
“Brian brings a wealth of experience managing complex IP transactions, especially in high-growth industries such as medical devices, biotechnology, and emerging technologies,” said Matthew Martin, chair of the Mechanical & Electromechanical Technologies Practice Group. “His background in counseling clients on both high-level transactional work and IP litigation strengthens our team’s ability to deliver tailored and effective solutions to address our clients’ diverse IP needs.”
Tomkins has extensive experience managing global IP portfolios and providing due diligence support for M&A and other transactions involving IP rights. He advises clients on strategies to address third-party IP risks, including clearance opinions, IP challenges, and licensing agreements. Tomkins also has experience in patent, trademark, copyright, and trade secret litigation, as well as pharmaceutical patent litigation under the Hatch-Waxman Act.
“We continue to invest in expanding our New York office and East Coast presence, and the addition of Brian is a key part of our strategy to strengthen our capabilities in the region,” said Anne Sekel, managing partner of Foley’s New York office. “His experience in managing significant IP transactions not only enhances our capabilities but also complements our M&A and Fund Formation & Investment Management teams here in New York, providing us with even greater depth to address the growing transactional and IP needs of our clients.”
“This move is a natural progression in my practice, and joining Foley was an easy decision,” said Tomkins. “The firm’s strong bench, extensive resources, and solid reputation will provide the support I need to continue addressing complex legal issues for our clients. I look forward to collaborating with a nationwide team, particularly in the life sciences and medical device sectors, to deliver comprehensive legal solutions to Foley’s diverse and expansive clientele.”
关于富理达律师事务所
Foley & Lardner LLP 是一家杰出的律师事务所，处于能源、医疗保健和生命科学、创新技术和制造业的中心。我们将目光投向法律之外，关注客户面临的不断变化的需求，并作为值得信赖的业务顾问，为客户提供创新、实用和有效的解决方案。我们在全球 26 个办事处拥有 1,100 名律师，可为客户提供从公司法律顾问到知识产权工作和诉讼支持的全方位服务，为客户的所有需求提供一站式解决方案。近两个世纪以来，富理达一直致力于提供最高水平的创新法律服务，以及对我们的员工、公司、客户和我们所服务的社区的管理。
